Centessa Pharmaceuticals Ownership | Who Owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals Ownership Summary
Centessa Pharmaceuticals is owned by 92.87% institutional investors, 0.49% insiders, and 6.64% retail investors. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 14.93% of CNTA shares. T. Rowe Price Health Sciences is the top mutual fund, with 2.22% of its assets in Centessa Pharmaceuticals shares.
CNTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Centessa Pharmaceuticals | 92.87% | 0.49% | 6.64% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 19.96M | 14.93% | $484.11M |
| Index venture life associates vi | 9.96M | 7.49% | $130.90M |
| General atlantic | 9.68M | 7.28% | $127.22M |
| Adage capital partners gp | 8.40M | 6.32% | $110.42M |
| Price t rowe associates inc /md/ | 5.36M | 4.61% | $89.85M |
| Janus henderson group | 4.91M | 4.22% | $82.22M |
| Avoro capital advisors | 5.00M | 3.76% | $65.70M |
| Farallon capital management | 4.53M | 3.40% | $59.52M |
| First light asset management | 4.29M | 3.23% | $56.42M |
| Fmr | 3.65M | 3.14% | $61.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Index venture life associates vi | 9.96M | 100.00% | $130.90M |
| Medicxi ventures management (jersey) | 19.96M | 65.03% | $484.11M |
| Foresite capital management vi | 1.25M | 9.26% | $16.47M |
| Allostery investments lp | 52.50K | 8.79% | $689.85K |
| First light asset management | 4.29M | 7.31% | $56.42M |
| Octagon capital advisors lp | 1.99M | 5.49% | $33.38M |
| Stempoint capital lp | 1.27M | 5.34% | $16.63M |
| Tcg crossover management | 2.89M | 4.34% | $37.99M |
| Saturn v capital management | 793.33K | 4.22% | $10.42M |
| General atlantic | 9.68M | 3.51% | $127.22M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 4.91M | 0.04% | 3.61M |
| Federated hermes | 1.75M | 0.07% | 1.75M |
| Rtw investments, lp | 1.53M | 0.29% | 1.48M |
| Adage capital partners gp | 8.40M | 0.19% | 1.45M |
| Balyasny asset management | 1.22M | 0.02% | 1.22M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vida ventures advisors | - | - | -3.93M |
| Ecor1 capital | - | - | -3.22M |
| Holocene advisors, lp | - | - | -2.26M |
| Perceptive advisors | 1.15M | 0.56% | -1.89M |
| T. rowe price investment management | 401.00 | - | -1.75M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Federated hermes | 1.75M | 0.07% | 1.75M | $42.43M |
| Polar capital | 1.00M | 0.07% | 1.00M | $13.14M |
| Capital world investors | 416.82K | 0.00% | 416.82K | $5.48M |
| Candriam s.c.a. | 347.60K | 0.03% | 347.60K | $4.57M |
| Cutter capital management, lp | 147.08K | 1.01% | 147.08K | $2.46M |
Sold Out
| Holder | Change |
|---|---|
| Bell investment advisors | -31.00 |
| Caldwell sutter capital | -43.00 |
| Spire wealth management | -70.00 |
| Simplex trading | -108.00 |
| Advisor group | -407.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 126 | -10.00% | 123,550,297 | -0.00% | 92 | 1.08% | 69 | -9.21% | 34 | -8.11% |
| Mar 31, 2025 | 141 | 18.49% | 124,864,870 | 0.36% | 93 | 0.82% | 75 | 22.95% | 38 | - |
| Dec 31, 2024 | 118 | 11.32% | 124,412,240 | 14.59% | 107 | 1.23% | 60 | -21.05% | 38 | 137.50% |
| Sep 30, 2024 | 106 | 29.27% | 108,573,103 | 25.51% | 93 | 1.50% | 76 | 72.73% | 16 | -15.79% |
| Jun 30, 2024 | 81 | 14.08% | 86,506,233 | 16.28% | 86 | 1.45% | 44 | -6.38% | 18 | 260.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 2.97M | 2.22% | -236.58K |
| Fidelity Select Biotechnology | 2.91M | 2.17% | -70.50K |
| Franklin Biotechnology Discv A(acc)USD | 1.18M | 0.88% | - |
| Polar Capital Biotech S Inc | 1.00M | 0.75% | - |
| Janus Henderson US SMID Cap Growth MA | 953.94K | 0.71% | 953.86K |
| Janus Henderson US SMID Cap Growth | 953.94K | 0.71% | -11.25K |
| Janus Henderson Triton D | 953.94K | 0.71% | -11.25K |
| American Century U.S. Small Cap Growth | 888.01K | 0.66% | 33.57K |
| American Century Small Cap Growth Inv | 888.01K | 0.66% | 33.57K |
| Fidelity VIP Mid Cap Initial | 702.20K | 0.52% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 27, 2025 | Accardi Mario Alberto | President, Orexin Program | Sell | $200.00K |
| Oct 15, 2025 | HUSSAIN IQBAL J | General Counsel | Sell | $134.44K |
| Sep 24, 2025 | Bush Tia L | Chief Technology & Quality Ofc | Sell | $840.00K |
| Sep 16, 2025 | Accardi Mario Alberto | President, Orexin Program | Sell | $158.51K |
| Sep 16, 2025 | Accardi Mario Alberto | President, Orexin Program | Sell | $16.34K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | 14 |
| 2025 Q2 | 2 | 12 |
| 2025 Q1 | - | 18 |
| 2024 Q4 | - | 18 |
CNTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools